amonafide has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balcerzak, SP; Buys, SS; Metch, B; Neefe, JR; Stuckey, WJ | 1 |
| Comis, RL; Nash, SL; O'Dwyer, PJ; Ozols, RF; Perez, RP | 1 |
2 trial(s) available for amonafide and Sarcoma
| Article | Year |
|---|---|
Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Nausea; Organophosphonates; Sarcoma; Soft Tissue Neoplasms; Vomiting | 1994 |
Phase II study of amonafide in advanced and recurrent sarcoma patients.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imides; Injections, Intravenous; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Recurrence; Sarcoma; Treatment Outcome | 1992 |